2 Medical Stocks to Consider Buying in June

With solid top and bottom-line growth on the horizon for HealthEquity (HQY) and iRadimed (IRMD), they are starting to look like viable investments for 2023 and beyond.

Related Keywords

Bristol Myers ,Pfizer ,Zacks Medical Services Industry ,Gilead Sciences ,Zacks Investment Research ,Image Source ,Zacks Investment ,Zacks Medical Instruments Industry ,Zacks Rank ,Zacks Medical Instrument ,Healthequity ,Jacks Medical ,Medical Stocks ,Medical Sector ,